Literature DB >> 1741538

Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.

J B Sedgwick1, W J Calhoun, G J Gleich, H Kita, J S Abrams, L B Schwartz, B Volovitz, M Ben-Yaakov, W W Busse.   

Abstract

Segmental antigen bronchoprovocation was used to define the nature of the inflammatory process in allergic airway disease. Bronchoalveolar lavage fluid obtained from allergic rhinitis patients 12 min after segmental antigen instillation (immediate response) revealed a significant increase in histamine and tryptase, but no cellular response. Repeat segmental lavage 48 h later (late response) showed marked and significant increases in both low and normal density eosinophils as well as striking elevations of eosinophil granular protein levels (major basic protein, eosinophil-derived neurotoxin, eosinophil cationic protein, and eosinophil peroxidase). Leukotriene C4, but not tryptase, concentrations were also consistently elevated in late lavage samples. Further, the late lavage samples showed a significant increase in interleukin-5 concentrations that correlated with the presence of eosinophils and eosinophil granular proteins. Neither eosinophils nor soluble mediators of eosinophils increased when normal subjects were similarly challenged with antigen. These data suggest that eosinophils are attracted to the airway during the late-phase allergic reaction and that IL-5 may produce changes in airway eosinophil density and promote the release of granular proteins to cause airway injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1741538     DOI: 10.1164/ajrccm/144.6.1274

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  31 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation.

Authors:  V Brusasco; E Crimi; R Pellegrino
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

3.  AJRCCM: 100-Year Anniversary. Focus on Asthma in Children and Adults.

Authors:  Fernando D Martinez; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2017-05-01       Impact factor: 21.405

4.  Macrophage-mediated candidacidal activity is augmented by exposure to eosinophil peroxidase: a paradigm for eosinophil-macrophage interaction.

Authors:  D L Lefkowitz; J A Lincoln; K R Howard; R Stuart; S S Lefkowitz; R C Allen
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

5.  Association analysis of interleukin 5 receptor alpha subunit (IL5RA) polymorphisms and asthma.

Authors:  Hyun Sub Cheong; Lyoung Hyo Kim; Byung Lae Park; Yoo Hyun Choi; Hae-Sim Park; Soo-Jong Hong; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  J Hum Genet       Date:  2005-10-06       Impact factor: 3.172

Review 6.  Cytokines. 3. Cytokines in asthma.

Authors:  D S Robinson; S R Durham; A B Kay
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

7.  Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Authors:  L B Schwartz; T R Bradford; C Rouse; A M Irani; G Rasp; J K Van der Zwan; P W Van der Linden
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

Review 8.  Evidence for Th2-type T helper cell control of allergic disease in vivo.

Authors:  D S Robinson; Q Hamid; M Jacobson; S Ying; A B Kay; S R Durham
Journal:  Springer Semin Immunopathol       Date:  1993

9.  Eosinophil granule cationic proteins regulate the classical pathway of complement.

Authors:  J M Weiler; R E Edens; C S Bell; G J Gleich
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

10.  IL-5 in post-traumatic eosinophilic pleural effusion.

Authors:  L Schandené; B Namias; A Crusiaux; M Lybin; R Devos; T Velu; P Capel; R Bellens; M Goldman
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.